TECH OUTLOOK 4DECEMBER - 20212012CXO INSIGHTSChallenges and Opportunities for AI in Drug DiscoveryDe-Risking the Preclinical Phase of Immunotherapy Drug DevelopmentRevamping Drug Discovery and Development through Technology InnovationBobby Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Research Institute, Inc.Ralph Gareus, Director Business Development, The Jackson LaboratoryDr. Michelle M. Chen, VP & Head of Corporate Development, WuXi Biologics [HKG:2269]161820FAST-TRACKING CLINICAL TRIALS WITH STERILE DRUG MANUFACTURING SERVICESColin MacKay, CEO
< Page 3 | Page 5 >